Plasmin inactivation in plasma

Area of Science:

• Biochemistry
• Hematology
• Immunology

Background:

• Plasmin is a key enzyme in fibrinolysis, responsible for breaking down blood clots.
• Several plasma proteins, including alpha2-macroglobulin, alpha1-antitrypsin, and C1-esterase inhibitor, are known inhibitors of plasmin.
• Understanding the relative contribution of these inhibitors to plasmin inactivation in vivo is critical for comprehending hemostasis and thrombosis.

Purpose of the Study:

• To investigate the role of different plasma inhibitors in the inactivation of plasmin.
• To determine which plasmin inhibitor correlates best with the overall plasmin-inactivating capacity of plasma.
• To assess the significance of alpha2-macroglobulin as a plasmin inhibitor in the context of thrombosis.

Main Methods:

• Performed "overall" inactivation tests of plasmin in human plasma, simulating conditions in circulating blood.
• Measured the immunological concentrations of alpha2-macroglobulin, alpha1-antitrypsin, and C1-esterase inhibitor.
• Correlated the measured inhibitor concentrations with the observed plasmin-inactivating capacity of the plasma.

Main Results:

• A significant positive correlation was found between the immunological concentration of alpha2-macroglobulin and the plasma's capacity to inactivate plasmin.
• No significant correlation was observed between the plasmin-inactivating capacity and the concentrations of alpha1-antitrypsin or C1-esterase inhibitor.
• These findings suggest alpha2-macroglobulin plays a dominant role in rapid plasmin inactivation.

Conclusions:

• Alpha2-macroglobulin appears to be the most important physiological inhibitor of plasmin in plasma.
• Its concentration is directly linked to the blood's ability to neutralize plasmin.
• This underscores the critical role of alpha2-macroglobulin in regulating fibrinolysis and potentially preventing thrombotic events.